The company said patients reported a 3.9 cm reduction in overall pain at three months on a 10 cm Visual Analog Scale. Patients also reported an average 4.3 cm decrease in back pain and an average 5 cm decrease in leg pain.
Results also showed that 69 percent of patients moved to a lower category on the Oswestry Disability Index and that 75 percent of patients reported being very satisfied or somewhat satisfied with their therapy at three months.
The results are consistent with a previous study conducted by Medtronic, the company said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.